about
The current practice of handling and reporting missing outcome data in eight widely used PROMs in RCT publications: a review of the current literatureMultiple imputation to deal with missing EQ-5D-3L data: Should we impute individual domains or the actual index?Difference in Restricted Mean Survival Time for Cost-Effectiveness Analysis Using Individual Patient Data Meta-Analysis: Evidence from a Case Study.Evaluation of software for multiple imputation of semi-continuous data.Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United KingdomSurgical stabilisation of the spine compared with a programme of intensive rehabilitation for the management of patients with chronic low back pain: cost utility analysis based on a randomised controlled trialThe effect of teamwork training on team performance and clinical outcome in elective orthopaedic surgery: a controlled interrupted time series studyPreferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statement.Lean Participative Process Improvement: Outcomes and Obstacles in Trauma Orthopaedics.A cluster randomised trial of strategies to increase cervical screening uptake at first invitation (STRATEGIC).Dealing with the health state 'dead' when using discrete choice experiments to obtain values for EQ-5D-5L heath statesAutoimmune markers for the diagnosis of rheumatoid arthritis in primary care: primary care diagnostic technology update.The multinational nature of cost-effectiveness analyses alongside multinational clinical trials.The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration.Mapping EQ-5D utility scores from the PedsQL™ generic core scales.Treatment pathways, resource use, and costs of endovascular coiling versus surgical clipping after aSAH.Valuation and Modeling of EQ-5D-5L Health States Using a Hybrid Approach.Mapping the modified Rankin scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome.Effectiveness of facilitated introduction of a standard operating procedure into routine processes in the operating theatre: a controlled interrupted time series.The costs and prognostic characteristics of ischaemic neurological deficit due to subarachnoid haemorrhage in the United Kingdom. Evidence from the MRC International Subarachnoid Aneurysm Trial.A multicentre, randomised controlled trial of position during the late stages of labour in nulliparous women with an epidural: clinical effectiveness and an economic evaluation (BUMPES).Healthcare and social services resource use and costs of self-harm patients.Effect of MRI on preterm infants and their families: a randomised trial with nested diagnostic and economic evaluation.Healthcare and wider societal implications of stillbirth: a population-based cost-of-illness study.What do we know about managing Dupuytren's disease cost-effectively?Assessing the Use of a Feedback Module to Model EQ-5D-5L Health States Values in Hong Kong.Computerised interpretation of the fetal heart rate during labour: a randomised controlled trial (INFANT).A combined teamwork training and work standardisation intervention in operating theatres: controlled interrupted time series study.Preferred reporting items for studies mapping onto preference-based outcome measures: the MAPS statement.Cost-effectiveness of referral for generic care or problem-solving treatment from community mental health nurses, compared with usual general practitioner care for common mental disorders: Randomised controlled trial.Estimating the association between SF-12 responses and EQ-5D utility values by response mapping.PREFERRED REPORTING ITEMS FOR STUDIES MAPPING ONTO PREFERENCE-BASED OUTCOME MEASURES: THE MAPS STATEMENT.Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement.Comparing the Efficacy of a Mobile Phone-Based Blood Glucose Management System With Standard Clinic Care in Women With Gestational Diabetes: Randomized Controlled Trial.Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement.The Impact of Risk Management Standards on Patient Safety: The Determinants of MRSA Infections in Acute NHS Hospitals, 2001-08*Handling Data Quality Issues to Estimate the Spanish EQ-5D-5L Value Set Using a Hybrid Interval Regression ApproachPreferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS StatementPreferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statementEpidemiology of fragile X syndrome: A systematic review and meta-analysis
P50
Q26773044-705BF7A5-8365-4F96-8051-D8F08B69D92FQ30874146-1CB591A5-BBD6-4E40-B5DC-A06C6BFCC875Q31056094-263AD793-F19C-4B16-AC49-CE27BFA33E08Q33290382-677E6DA5-8994-489A-94BE-D06449971535Q33868965-A27C3BD0-8B38-46FA-977F-F406A635FBA7Q33940689-41B68FE1-DEBD-483D-8FF8-5209BFDD26EEQ35539392-C2BB7F0D-161E-4623-A95D-9CFE917B65C9Q35908125-4E5B2FCE-A581-442B-8674-B268D6ADE50CQ36001811-32F9073F-95C1-461B-A63B-3A3FB7B104F8Q36134739-4FBF6D45-0400-4F6A-8149-DA66EC52B122Q37057599-5D635B86-7291-44A1-88CF-450FC08077FCQ37196816-753B60C1-667A-41CD-8E69-8E5F9B5C4757Q37776317-3C3E7CE2-FDA9-4B80-911B-E59EC1D5A631Q38558706-7F5DB7AD-74FF-40E7-85FB-D6A0B81BB2CFQ39213220-D3BB28B7-D6D6-4C20-BEB5-DB9BFB9553A1Q40148400-5E6B169C-451F-4B3B-A06F-BF6B61A1ABB9Q41673724-D89D18B1-F6F6-45B9-839C-CB47B26F2620Q43937776-69E2DB33-84C0-4D38-A288-45F42BA3AFFFQ45357806-3397F981-81A9-4658-A4BA-62344EC69CA3Q46207152-8A56D01C-0C5E-4831-8D1B-57CCF48C0C8FQ47224854-915A47C1-A960-4B01-ABCF-CDC6B416DD99Q47265264-8A68BBC6-4D26-4096-8311-95E85B2EFB37Q47292200-E9724DE9-FCA2-4C11-815A-E3B5DE0BA19BQ47653791-37A31725-4672-4EF7-A042-AEF5D32E02C9Q47711682-CFB43A41-28B9-43B6-AF2F-746FD7A048E8Q47822197-DBEC824C-6F45-42DA-8836-E4E9FB664A63Q50046195-2F15B941-BD05-4FEC-9300-9D1B6BF96C40Q50464713-C9DB9F30-4131-4826-9F90-825B67108397Q51024067-5D12F625-1F3E-47C8-9EE1-0F24B2451065Q51915313-938EFD0E-96B3-42EA-9218-AC3C0DDDE7DCQ51949438-9FF13829-A40B-4DAF-9858-0C28F1B0063FQ53397964-6814BD15-0A8E-46F1-BE9B-E198EF871CB6Q53399248-2BCB5768-B859-4C40-A09A-717275948FA2Q53429911-D3E0B112-B3EB-47FE-8F4E-BCD649377F0CQ54901654-42A24557-D719-4EB5-89BB-1A7FE9018CE0Q59168236-D0355FF5-702F-41CD-8495-5CE9241E2A7FQ61844798-F58981E0-ADBD-432C-A942-2DB6DDDDD8A7Q61844803-6386BD48-C260-4469-972C-4BFF123B1B87Q61844807-DBE2BC50-1687-45D2-9E17-DDD437CC86C6Q61844810-E400C8B9-B74D-4F46-B532-31AF3AB6FEE2
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Oliver Rivero-Arias
@ast
Oliver Rivero-Arias
@en
Oliver Rivero-Arias
@es
Oliver Rivero-Arias
@nl
Oliver Rivero-Arias
@sl
type
label
Oliver Rivero-Arias
@ast
Oliver Rivero-Arias
@en
Oliver Rivero-Arias
@es
Oliver Rivero-Arias
@nl
Oliver Rivero-Arias
@sl
prefLabel
Oliver Rivero-Arias
@ast
Oliver Rivero-Arias
@en
Oliver Rivero-Arias
@es
Oliver Rivero-Arias
@nl
Oliver Rivero-Arias
@sl
P106
P1153
8453027100
P1960
jtjS0GoAAAAJ
P21
P31
P496
0000-0003-2233-6544